Genprex, Inc.
NASDAQ:GNPX
0.738 (USD) • At close January 14, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 0.015 | 23.831 | 0.023 | 0.023 | 0.013 | 0.006 | 0 | 0 | 0 |
| Gross Profit
| -0.015 | -23.831 | -0.023 | -0.023 | -0.013 | -0.006 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 17.617 | 11.51 | 8.608 | 7.303 | 1.967 | 0.971 | 0.29 | 0.355 | 0.202 |
| General & Administrative Expenses
| 13.444 | 12.295 | 10.97 | 10.636 | 8.703 | 11.386 | 3.019 | 3.776 | 0.866 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 13.444 | 12.295 | 10.97 | 10.636 | 8.703 | 11.386 | 3.019 | 3.776 | 0.866 |
| Other Expenses
| 0 | 0.026 | 0.023 | 0.023 | 0.013 | 0.006 | 0.003 | 0 | 0 |
| Operating Expenses
| 31.061 | 23.831 | 19.601 | 17.962 | 10.683 | 12.364 | 3.312 | 4.132 | 1.07 |
| Operating Income
| -31.076 | -23.831 | -19.601 | -17.962 | -10.683 | -12.364 | -3.312 | -4.132 | -1.07 |
| Operating Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 0.215 | 0.09 | 0.005 | 0.019 | 0.028 | -0.009 | -0.002 | 0 | 0 |
| Income Before Tax
| -30.86 | -23.741 | -19.596 | -17.943 | -10.655 | -12.372 | -3.314 | -4.132 | -1.07 |
| Income Before Tax Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0 | 5.722 | -0.005 | -0.019 | -0.131 | 0.029 | 0 | 0 | 0 |
| Net Income
| -30.86 | -29.463 | -19.59 | -17.924 | -10.655 | -12.372 | -3.314 | -4.132 | -1.07 |
| Net Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -22.58 | -24.59 | -16.64 | -20.18 | -26.64 | -35.97 | -11.55 | -15.3 | -23.25 |
| EPS Diluted
| -22.56 | -24.58 | -16.64 | -20.18 | -26.59 | -35.94 | -11.53 | -15.26 | -22.93 |
| EBITDA
| -31.061 | -23.805 | -20.648 | -17.939 | -10.642 | -12.328 | -3.309 | -4.131 | -1.068 |
| EBITDA Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |